BioSpace News Archive

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, announced today that it will be presenting at the H.C. Wainwright & Co., 22nd Annual Global Investment Conference on Monday, September 14, 2020

TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT)

Cynosure announced today that Anne Gates, former President at MGA Entertainment, the world’s largest private toy company, and Executive Vice President and CFO of The Walt Disney Company’s Consumer Products Division, has been appointed to its board of directors and will chair the company’s audit committee.

Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company’s industry-leading MPS antibody discovery platform for multipass membrane proteins.

Naturepedic is asking consumers to support the efforts of The Max Cure Foundation and multiple stakeholders, including other CAC2 members, to bring attention to the increase in childhood cancer diagnoses and prevention measures in honor of September’s Childhood Cancer Awareness month.

Dr. Richard Levin was named a Rezūm® Center of Excellence in 2020; he is only the second Rezūm Center of Excellence in the U.S. and the first in the Northeast and Mid-Atlantic region.

Acne affects up to 50 million Americans annually, including people of all skin types and complexions.

Today CDISC and Microsoft co-hosted a virtual workshop to shape the future of standards and technology by planning the next generation CDISC Library. The CDISC Library metadata repository serves as the single, trusted, authoritative source of CDISC standards metadata for the clinical research community. “CDISC is excited to collaborate with Microsoft on this important next step, which will set the pace globally f

LabConnect, the preeminent provider of clinical trial central lab services, announced the expansion of its Johnson City facility to support its significant growth in cell and gene therapy and immuno-oncology studies.

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the Oppenheimer Fall Healthcare, Life Sciences, & MedTech Summit,